28.07.2011 • NewsBraskemDowDow Chemicals

Braskem to Buy Dow Chemical's Polypropylene Business

Braskem said Wednesday that it has agreed to buy Dow Chemical's global polypropylene business for $323 million.

Braskem said the deal represents an important step in its growth strategy in the Americas and also consolidates its polypropylene leadership in the U.S.

The business has total annual polypropylene production capacity of 1.1 million tons with four industrial plants in the U.S. and Germany.

The two plants located in the U.S., at Freeport and Seadrift, Texas, add up to 1.4 million tons, increasing Braskem's annual PP capacity by 50% in the region. The two plants located in Germany, at the petrochemical complexes of Wesseling and Schkopau, have annual capacity of 544,000 tons of PP.

The transaction is expected to close by the third quarter 2011 pending regulatory approvals.

 

 

Whitepaper

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)
Setting the Standard

Excellence in Pharmaceutical Distribution and The Critical Role of Good Distribution Practice (GDP)

Are you ready to elevate your pharmaceutical operations? Download our exclusive whitepaper and discover how compliance with Good Distribution Practice (GDP) is essential for the safety and integrity of pharmaceuticals.

Free Virtual Event

Vaccine Manufacturing
Bioprocess Forum

Vaccine Manufacturing

Join global experts and innovators for a two-day virtual event exploring the latest breakthroughs and best practices in vaccine manufacturing. Discover how new technologies and process innovations are shaping the future of vaccine production, safety, and scalability.